Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Hai Le

Orthopaedic Surgery Sacramento, CA Medical Doctor

NPI 1447665310 CMS profile 432908

4860 Y St Ste 4860Y, Sacramento, CA 95817

Open in the dashboard

General payments

$113,921

204 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$44,500 paid to institutions, not to them · program year 2025

Through program year 2025, Hai Le of Sacramento, CA is reported in the CMS Open Payments database as having received $113,921 across 204 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $44,500 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $25,247 44
2024 General $51,586 89
2023 General $35,129 52
2022 General $1,519 9
2021 General $326 6
2019 General $113 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hai Le
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Hai Le were reported at $25,247. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Hai Le Orthopaedic Surgery median Middle half National median
2019 $113 $644 $140–$2,844 $163
2020 $0 $312 $75–$1,860 $114
2021 $326 $520 $117–$2,495 $132
2022 $1,519 $598 $128–$2,731 $149
2023 $35,129 $461 $128–$2,264 $160
2024 $51,586 $497 $134–$2,475 $164
2025 $25,247 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $51,433 27 payments
  2. Carlsmed, Inc. $29,658 41 payments
  3. VB Spine LLC $12,425 9 payments
  4. Alphatec Spine, Inc $5,723 9 payments
  5. Globus Medical, Inc. $2,956 27 payments
  6. Orthofix Medical, Inc. $2,151 16 payments
  7. Synthes GmbH $1,897 3 payments
  8. NuVasive, Inc. $1,880 19 payments
  9. Spineology Inc. $1,291 12 payments
  10. Kyocera Medical Technologies, Inc. $919 2 payments
  11. Other $3,589 39 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $83,938 22 payments
  2. Travel and Lodging $20,242 61 payments
  3. Food and Beverage $9,742 121 payments
Products named General payments · program years 2019–2025
  1. aprevo Orthopedics/Orthopedic Surgery $26,117 34 payments
  2. CASCADIA INTERBODY SYSTEM $18,525 1 payment
  3. EVEREST SPINAL SYSTEM $16,276 11 payments
  4. CAPRI CORPECTOMY CAGE SYSTEM $13,063 4 payments
  5. OZARK CERVICAL PLATE SYSTEM Spine $13,000 1 payment
  6. OZARK CERVICAL PLATE SYSTEM Spine $13,000 1 payment
  7. YUKON OCT SPINAL SYSTEM $13,000 1 payment
  8. Vulcan Spinal System $12,425 9 payments
  9. Battalion TLIF - PC $3,750 1 payment
  10. aprevo Orthopedics/Orthopedic Surgery $1,955 4 payments
  11. Other $19,756 154 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

11

Median for Orthopedic Surgery: 203

Drug cost

$62

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 11 $62

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 52 billing codes

Paid by Medicare

$243,864

Medicare's payments for the services billed

Medicare patients

342

Average age 73

Services billed

885

195 women, 147 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 35%
Depression 33%
Ischemic heart disease 25%
Osteoporosis 25%
COPD 18%
Heart failure 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

204 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record